How common is pancreatic cancer in India — and what the numbers really show

People who search for pancreatic cancer India statistics are rarely after a number for its own sake. Usually something has happened first — a symptom that will not settle, a relative newly diagnosed, a scan report with a word on it nobody explained — and the number is a way of asking whether this is likely to be happening to you. So it is worth saying the honest answer at the top: pancreatic cancer is one of the less common cancers in India, well behind breast, oral, lung and cervical cancer in every registry that records it. It is also not rare, because in a country this size an uncommon cancer still means a great many families each year.

Two things are consistently true in the Indian data. The first is that pancreatic cancer incidence in India is lower than in Western Europe, North America and Japan. The second is that it is rising, particularly in the long-running urban registries. Part of that rise is real — people are living longer, and this is overwhelmingly a cancer of later life, while smoking, obesity and diabetes have all become more common. Part of it is better detection: cross-sectional imaging is far more available now than it was a generation ago, and a tumour that would once have been recorded only as an abdominal illness is now given its proper name.

What nobody can honestly give you is a precise national count. India has no single register of every cancer diagnosed in the country. The figures that circulate are careful estimates modelled outward from the areas that are covered, and for a deep-seated, hard-to-diagnose cancer like this one the true number is widely accepted to be higher than the recorded one. That is not a reason to distrust the data. It is a reason to read it for what it is: a description of a population, not a verdict on a person.

This page explains where the Indian figures come from, why they look the way they do, what each kind of number can and cannot answer, and what actually decides your own risk. If you want the wider picture first — symptoms, diagnosis, treatment and support in one place — the complete pancreatic cancer guide covers all of it.

• Age carries more weight than anything else. Risk climbs steadily from middle age onwards and most diagnoses are made in the sixties and seventies. Below middle age it is genuinely uncommon, though not impossible.
• Smoking is the largest risk you can change. It is the single most consistently proven modifiable cause of this cancer anywhere in the world, and the risk falls after stopping.
• Diabetes needs a careful, unalarming reading. Long-standing diabetes modestly raises risk. Diabetes appearing for the first time in later life alongside unexplained weight loss is worth mentioning to your doctor — not because it usually means cancer, because it almost never does, but because it occasionally deserves a look.
• A family pattern changes the conversation. Two or more close relatives with pancreatic cancer, or a known inherited change such as BRCA, PALB2, ATM, CDKN2A or Lynch syndrome, moves you into a defined high-risk group. That is a genetic counselling conversation, and we hold those in-house.
• Chronic pancreatitis is a recognised risk factor. Long-standing inflammation of the pancreas, whatever its cause, raises risk over many years and warrants a doctor who knows your history rather than a one-off opinion.
• There is no screening test for the general public. NCCN guidance supports surveillance only for defined high-risk groups, not for average-risk adults, and no blood test is a substitute — is there a screening test for pancreatic cancer explains exactly who qualifies and who does not.
• Painless jaundice means a check this week. Yellowing of the eyes or skin with dark urine and pale stools, arriving without fever or pain, is the one pattern that should not wait. Pain, by contrast, is a late and unreliable guide — is pancreatic cancer painful sets out why waiting for pain is the wrong test.

1. 1

   We ask what actually brought you here

   A symptom, a relative's diagnosis, or a number you read at two in the morning are three different consultations. Separating them early is what stops an anxious afternoon turning into a month of unnecessary tests.

   Free 45-minute consultation
2. 2

   History and family history, taken properly

   Age, smoking history, diabetes, pancreatitis, weight change, and who in the family has had which cancer at what age. Where a pattern emerges, genetic counselling follows in the same building.

   In-house at CION
3. 3

   If there are symptoms, imaging answers the question, not a blood test

   A pancreatic-protocol contrast CT or an MRI with MRCP is what actually looks at the pancreas. A blood marker cannot rule this out — you can have pancreatic cancer with a normal CA 19-9, which is exactly why it is not used for screening.

   Ordered and reported in-house at CION
4. 4

   If the answer is reassuring, we say so and stop

   Most people who come in worried after reading about this cancer do not have it. We would rather tell you that plainly, with the scan to back it up, than keep you on a follow-up list that serves nobody.

   In-house at CION
5. 5

   If something needs a closer look, we arrange it and tell you where

   Tissue is usually obtained by endoscopic ultrasound with a fine-needle sample. We arrange it, we sit in on the decision, and we tell you in advance where it happens and who invoices you.

   Coordinated with specialist endoscopy partners
6. 6

   If a diagnosis is confirmed, the team is assembled the same week

   Who leads the care surprises many people — which doctor treats pancreatic cancer explains the roles, and pancreatic cancer treatment in Hyderabad sets out what is actually available.

   Tumour board at CION

Being clear about this at the start saves a difficult conversation later. Your first consultation is free and lasts 45 minutes, and it is a genuine review of your history and your reports rather than a booking appointment.

Delivered in-house at CION, across 35+ centres in Telangana and Andhra Pradesh: the ordering and reporting of pancreatic-protocol CT, MRI/MRCP, CA 19-9 and routine bloods; genetic counselling and high-risk family assessment; medical oncology — chemotherapy before surgery, after surgery and for advanced disease, PARP-inhibitor-class maintenance where an inherited BRCA change is found, immune checkpoint inhibitor therapy where the tumour is mismatch-repair deficient, and systemic treatment for neuroendocrine tumours including somatostatin-analogue-class therapy. Also radiation, chemoradiation and SBRT; nutrition and pancreatic enzyme replacement; pain relief, psycho-oncology and supportive care; and survivorship follow-up.

Coordinated with specialist HPB, gastroenterology and endoscopy partner centres, and may be billed there: all pancreatic surgery, including the Whipple procedure and distal pancreatectomy; endoscopic ultrasound with biopsy; ERCP and biliary or duodenal stenting; staging laparoscopy; coeliac plexus block for pain; PET-CT and DOTATATE PET; and peptide receptor radionuclide therapy. We arrange these and we stay in the decision, but we do not describe them as our own theatre or endoscopy lists, because they are not.

If you are here because you are frightened, the population data is on your side and it is worth saying so directly. Set against the cancers that fill Indian oncology clinics, this one is uncommon. Most abdominal pain is not pancreatic cancer. Most back pain is not pancreatic cancer. Most weight loss has an ordinary explanation, and most people who spend an evening reading about this disease do not have it.

The same data, read fairly, also carries a caution. Because this cancer is uncommon, it is not the first thing anyone thinks of, and that is one of the reasons it tends to be found late. A national figure is therefore useless as a personal reassurance and useless as a personal alarm. What is useful is the pattern: a symptom that is persistent rather than fleeting, progressive rather than stable, and unexplained by anything else. And painless jaundice, which needs looking at this week regardless of how uncommon the cancer is.

If a diagnosis has already been made in your family, the questions change entirely and the statistics stop being the point. What matters then is the tumour type, whether it can be removed, and how it responds to treatment. Where pancreatic cancer spreads first explains what the staging scans are looking for, and the answers to the rest of the common questions are gathered in the complete pancreatic cancer guide.

Medical disclaimer: This page explains how pancreatic cancer incidence is recorded and estimated in India and what those figures do and do not describe, and is reviewed by a CION medical oncologist with reference to NCCN guidance on pancreatic adenocarcinoma and high-risk surveillance. It deliberately states no incidence, prevalence or survival figure, because published national numbers are modelled estimates and none of them describes an individual. It is general information and is not a substitute for assessment of your own symptoms and history by a doctor who knows you. Imaging and CA 19-9 ordering and reporting, genetic counselling, chemotherapy, radiation, chemoradiation and SBRT, nutrition and enzyme support, pain relief, psycho-oncology and survivorship care are delivered by CION; all pancreatic surgery, endoscopic ultrasound and biopsy, ERCP and stenting, staging laparoscopy, coeliac plexus block, PET-CT and DOTATATE PET, and peptide receptor radionuclide therapy are coordinated with specialist HPB, gastroenterology and endoscopy partner centres and may be billed there.